Johnson & Johnson (JNJ) posts promising Phase 2b trial results for its chemotherapy releasing system TAR-200 in bladder ...

Sasanlimab, a subcutaneously administered PD-1 inhibitor, in combination with BCG represents the first potential treatment advancement for BCG-naïve, high-risk non-muscle invasive bladder cancer in ...

Terry Bradshaw was the golden-armed leader of the Pittsburgh Steelers dynasty, a two-time Super Bowl MVP, a four-time ...

First results from SunRISe-1 (Cohort 4) show strong disease-free survival rates across high-grade papillary tumours, demonstrating the potential for bladder preservation with 94 percent of patients ...

Dr. Matthew Galsky highlights the impact of Imfinzi’s adjuvant approval for patients with muscle-invasive bladder cancer ...

Chris Cotton is raising money for cancer centers after being told the day after his 50th birthday that what he thought was a ...

Bacillus Calmette-Guérin (BCG) remains the primary treatment for patients with high-risk bladder cancer, but resistance develops in 30% to 40% of cases. The use of oncolytic viruses has emerged as a ...

In patients with bladder cancer, lactylation score may predict survival and efficacy of immune checkpoint inhibitor treatment, according to researchers.

A new study published in the Asian Journal of Urology has found that certain cannabis strains rich in cannabinoids like CBC ...

A 50-year-old resident of Cheshire, who mistook his initial symptoms of bladder cancer to be a UTI, drank cranberry juice as ...

An AI-powered blood test for detecting 12 common cancers has been awarded government funding for further clinical trials.

A parasitic worm may raise the risk of cervical cancer through several mechanisms, scientists have found, although HPV ...